Voyageur Pharmaceuticals Ltd VM

Morningstar Rating
CA$0.12 0.00 (0.00%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VM is trading at a LOCK|^#b>k premium.
Price
CA$0.12
Fair Value
LOCK|!Vp^lB
Uncertainty
LOCK|%G $^kzS
1-Star Price
LOCK|t%!&xJ
5-Star Price
LOCK|F%Jv&kT
Economic Moat
LOCK|QZL
Capital Allocation
—

Trading Information

Previous Close Price
CA$0.12
Day Range
CA$0.12–0.12
52-Week Range
CA$0.07–0.20
Bid/Ask
CA$0.12 / CA$0.12
Shares Outstanding
227.58M
Market Cap
CA$27.31M
Volume/Avg
500 / 119,450

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
449.44
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Voyageur Pharmaceuticals Ltd is a Canadian development-stage pharmaceutical company developing and selling barium and iodine active pharmaceutical ingredients (API) and high-performance, cost-effective imaging contrast agents for medical radiology. Its product portfolio comprises SmoothX (a barium sulfate suspension), SmoothHD, SmoothLD (a low-density barium suspension solution), VisionHD (a high-density barium powder suspension), VisionLD, V-Gas, and others. Additionally, the company has interests in two mineral properties: Frances Creek and Jubilee Mountain, located in the province of British Columbia, Canada, and the ULI Project in the state of Utah, United States of America.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
—

Valuation

Metric
VM
Price/Earnings (Normalized)
—
Price/Book Value
6.44
Price/Sales
449.44
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
VM
Quick Ratio
2.47
Current Ratio
3.05
Interest Coverage
—
Quick Ratio
VM

Profitability

Metric
VM
Return on Assets (Normalized)
−62.65%
Return on Equity (Normalized)
−140.78%
Return on Invested Capital (Normalized)
−137.34%
Return on Assets
VM

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|x<X#V@rHLOCK|@t<@x$72B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|ks!NKDvCLOCK|&QDY$51B
Haleon PLC ADR
HLN
LOCK|M?>qS?LOCK|z>$40B
Zoetis Inc Class A
ZTS
LOCK|wr>vTX@LOCK|^G&$34B
Viatris Inc
VTRS
LOCK|T%%l>hLOCK|cd$24B
Elanco Animal Health Inc
ELAN
LOCK|s!LOCK|#s!$13B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|rHhKPrLOCK|N#$12B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|tLBHj$LOCK|?lj$4B
Prestige Consumer Healthcare Inc
PBH
LOCK|QgJ#MfhLOCK|C$&^^$2B
Perrigo Co PLC
PRGO
LOCK|c>vsx@LOCK|#%$2B

Sponsor Center